Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae

作者: Katie Lynn Hammer , Andrew Stoessel , Julie Ann Justo , P. Brandon Bookstaver , Joseph Kohn

DOI: 10.1016/J.AJIC.2016.05.017

关键词:

摘要: Background The combination of inherent antimicrobial resistance and high mortality after bloodstream infections (BSIs) caused by chromosomally mediated AmpC-producing Enterobacteriaceae (CAE) emphasizes the importance identifying patients at risk BSI because these bacteria. This retrospective case-control study examines chronic hemodialysis among other factors for CAE. Methods Hospitalized adults with from January 1, 2010-June 30, 2014, 2 large community hospitals in Southeastern United States were identified. Multivariate logistic regression was used to examine CAE BSI. Results Among 831 isolates, 106 (13%) met phenotypic definition Enterobacter spp accounted 47% (50/106) BSIs. Chronic an independent factor (adjusted odds ratio [aOR], 2.34; 95% confidence interval [CI], 1.21-4.44). Other predictors included nosocomial acquisition (aOR, 1.72; CI, 1.02-2.87) exposure β-lactam antibiotics within last 30 days 2.39; 1.37-4.14). Conclusions To our knowledge, this is first demonstrate increased end-stage renal disease undergoing hemodialysis. highlights effective infection prevention stewardship interventions clinics. Further studies impact on intestinal microbiota rates colonization patient population are warranted.

参考文章(32)
M. N. Al-Hasan, J. E. Eckel-Passow, L. M. Baddour, Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 31, pp. 1163- 1171 ,(2012) , 10.1007/S10096-011-1424-6
Markus Hilty, Parham Sendi, Salome N. Seiffert, Sara Droz, Vincent Perreten, Andrea M. Hujer, Robert A. Bonomo, Kathrin Mühlemann, Andrea Endimiani, Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy? International Journal of Antimicrobial Agents. ,vol. 41, pp. 236- 249 ,(2013) , 10.1016/J.IJANTIMICAG.2012.10.022
Lisa M. Blanchette, Joseph L. Kuti, David P. Nicolau, Michael D. Nailor, Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae Scandinavian Journal of Infectious Diseases. ,vol. 46, pp. 803- 808 ,(2014) , 10.3109/00365548.2014.954262
Sarah E. Cain, Joseph Kohn, P. Brandon Bookstaver, Helmut Albrecht, Majdi N. Al-Hasan, Stratification of the Impact of Inappropriate Empirical Antimicrobial Therapy for Gram-Negative Bloodstream Infections by Predicted Prognosis Antimicrobial Agents and Chemotherapy. ,vol. 59, pp. 245- 250 ,(2015) , 10.1128/AAC.03935-14
George A. Jacoby, AmpC β-Lactamases Clinical Microbiology Reviews. ,vol. 22, pp. 161- 182 ,(2009) , 10.1128/CMR.00036-08
M. J. Siedner, A. Galar, B. B. Guzman-Suarez, D. W. Kubiak, N. Baghdady, M. J. Ferraro, D. C. Hooper, T. F. O'Brien, F. M. Marty, Cefepime vs Other Antibacterial Agents for the Treatment of Enterobacter Species Bacteremia Clinical Infectious Diseases. ,vol. 58, pp. 1554- 1563 ,(2014) , 10.1093/CID/CIU182
Ali Ramezani, Dominic S. Raj, The Gut Microbiome, Kidney Disease, and Targeted Interventions Journal of the American Society of Nephrology. ,vol. 25, pp. 657- 670 ,(2014) , 10.1681/ASN.2013080905
Ruben Poesen, Karen Windey, Ellen Neven, Dirk Kuypers, Vicky De Preter, Patrick Augustijns, Patrick D’Haese, Pieter Evenepoel, Kristin Verbeke, Björn Meijers, None, The Influence of CKD on Colonic Microbial Metabolism Journal of The American Society of Nephrology. ,vol. 27, pp. 1389- 1399 ,(2016) , 10.1681/ASN.2015030279
N Deborah Friedman, Keith S Kaye, Jason E Stout, Sarah A McGarry, Sharon L Trivette, Jane P Briggs, Wanda Lamm, Connie Clark, Jennifer MacFarquhar, Aaron L Walton, L Barth Reller, Daniel J Sexton, Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Annals of Internal Medicine. ,vol. 137, pp. 791- 797 ,(2002) , 10.7326/0003-4819-137-10-200211190-00007